The malaria parasite, Plasmodium, exports protein products to the infected erythrocyte to introduce modifications necessary for the establishment of nutrient acquisition and surface display of host interaction ligands. Erythrocyte remodeling impacts parasite virulence and disease pathology and is well documented for the human malaria parasite Plasmodium falciparum, but has been less described for other Plasmodium species. For P. falciparum, the exported protein skeleton-binding protein 1 (PfSBP1) is involved in the trafficking of erythrocyte surface ligands and localized to membranous structures within the infected erythrocyte, termed Maurer's clefts. In this study, we analyzed SBP1 orthologs across the Plasmodium genus by BLAST analysis and conserved gene synteny, which were also recently described by de Niz et al. (2016) . To evaluate the localization of an SBP1 ortholog, we utilized the zoonotic malaria parasite, Plasmodium knowlesi. Immunofluorescence assay of transgenic P. knowlesi parasites expressing epitope-tagged recombinant PkSBP1 revealed a punctate staining pattern reminiscent of Maurer's clefts, following infection of either monkey or human erythrocytes. The recombinant PkSBP1-positive puncta co-localized with Giemsa-stained structures, known as 'Sinton and Mulligan' stipplings. Immunoelectron microscopy also showed that recombinant PkSBP1 localizes within or on the membranous structures akin to the Maurer's clefts. The recombinant PkSBP1 expressed in P. falciparum-infected erythrocytes co-localized with PfSBP1 at the Maurer's clefts, indicating an analogous trafficking pattern. A member of the P. knowlesi 2TM protein family was also expressed and localized to membranous structures in infected monkey erythrocytes. These results suggest that the trafficking machinery and induced erythrocyte cellular structures of P. knowlesi are similar following infection of both monkey and human erythrocytes, and are conserved with P. falciparum.
Introduction
Despite a 37% decrease in the global incidence of malaria due to interventions in the past 15 years, the malaria parasite has consistently innovated ways to thwart control efforts. Resistance to first-line drugs for treating malaria has long been a challenge and now antimalarial drugs must be developed to limit the emergence of artemisinin-resistant parasites [1] . Control efforts largely focus on the virulent Plasmodium falciparum, and the widespread Plasmodium vivax, with lesser emphasis targeting other Plasmodium species that cause human malaria. The World Health Organization has recognized Plasmodium knowlesi as the causative agent of the fifth human malaria [2] . P. knowlesi infection sometimes results in fatal illness due to high levels of parasitemia as a consequence of the short 24-hour blood stage replication cycle of the parasite [3] . P. knowlesi is traditionally considered a non-human malaria parasite, found in Southeast Asia infecting macaque monkeys, and humans as a zoonotic infection [4] . For such zoonotic parasites, increased direct or close contact with humans and animals results from urbanization, and for P. knowlesi represents another obstacle in the general fight against malaria. Human-animal contact is pivotal in expanding host niches potentiating the adaptation of simian Plasmodium species to human hosts [5, 6] .
The increased clinical descriptions of naturally acquired human infection [7, 8] underscore the importance of P. knowlesi in malaria research, with the complementing view that it also provides an experimental model for P. vivax. Before it became a public health concern, P. knowlesi had been an invaluable tool in in vivo and in vitro studies of malaria parasite processes such as antigenic variation [9] and host invasion [10] . Lines of P. knowlesi have been recently adapted to in vitro culture using human erythrocytes [11, 12] , thus making interrogation of P. knowlesi cellular biology more accessible.
Malaria parasites export to the infected erythrocyte numerous self-encoded proteins which facilitate import of nutrients into the parasite and mediate erythrocyte surface exposition of ligands. Some members of the 'exportome' facilitate the establishment of parasite-induced structures in erythrocytes of varied morphology and physiology across Plasmodium [13] . In P. falciparum, the newly formed membranous structures termed Maurer's clefts (MCs) are thought to be protein marshaling platforms where exported proteins, such as the Pfmc-2TM integral membrane proteins [14] , either reside or transiently associate en route to the erythrocyte membrane [15] . The well characterized P. falciparum skeleton-binding protein 1 (PfSBP1) is an exported integral membrane protein that resides on the MC membrane. PfSBP1 has been shown to participate in protein interactions that anchor MCs to the erythrocyte cytoskeleton [16, 17] ; however, the absence of PfSBP1 does not affect the number, morphology, and position of MCs [18, 19] . PfSBP1 is not involved in the trafficking mechanism of some MC-associated proteins, such as ring exported protein-1 (REX1) [20] , membrane-associated histidine-rich protein 1 (MAHRP1) [21, 22] , and knob-associated histidine-rich protein (KAHRP) [23] , but is required for transport of erythrocyte surface variant ligand termed P. falciparum erythrocyte membrane protein 1 (PfEMP1) to the erythrocyte surface [18, 19] . Surface display of PfEMP1 is also affected by the absence of proteins like MAHRP1 [22] , PfEMP3 [24] as well as the soluble KAHRP [23] implying that the role of PfSBP1 in the erythrocyte surface display of the antigens is vital but not sufficient. The first Plasmodium gene family demonstrated to undergo antigenic variation was found in P. knowlesi; specifically, the Schizont Infected Cell Agglutination variant antigen (SICAvar). This protein shares an intracellular tryptophan-rich motif, and might be analogous in function to the P. falciparum erythrocyte surface ligand PfEMP1 [25] [26] [27] . Recently, the SBP1 ortholog (PbSBP1) of the rodent malaria parasite Plasmodium berghei and some other Plasmodium species were reported [28] . PbSBP1 localizes to the dot-like structures in the cytoplasm of the infected erythrocytes. Disruption of PbSBP1 resulted in the reduced activity of the cytoadhesion, which was restored by the complementation of P. falciparum SBP1, indicating that the dot-like structures in P. berghei-infected erythrocytes are functionally equivalent to the Maurer's clefts in P. berghei-infected erythrocytes. However, no PfSBP1 orthologs have been characterized in P. knowlesi and it is not clear whether P. knowlesi possess functionally equivalent MC-like structures, given that the morphologies of parasite-induced erythrocyte structures vary across species [13, 29] .
To better understand the structures and mechanisms underlying Plasmodium protein export, we have further analyzed SBP1 orthologs in other Plasmodium species. Using the zoonotic P. knowlesi, we explore the hitherto unknown protein export structures and mechanism by examining the localization of the P. knowlesi SBP1 (PkSBP1) ortholog which is likely similarly important to PfSBP1 and PbSBP1, for which gene knockouts have been performed [18, 28] .
Results

Analysis of SBP1 orthologs
A candidate SBP1 protein for P. knowlesi was identified by BLASTP analysis using the P. falciparum SBP1 amino acid sequence as a query of GenBank and the Plasmodium genome databases accessed at PlasmoDB independently from the recent report by de Niz et al. (2016) [28] . Candidate SBP1 proteins for other Plasmodium were identified by the same manner using the putative P. knowlesi SBP1 sequence. Because of the low similarity in amino acid sequences and lack of signature domains or motifs, orthology was confirmed by the observation of conservation of synteny for the predicted sbp1 genes within their extended loci across Plasmodium ( Fig  1A) . To this end, sbp1 was identified to be conserved as a single copy gene across the Plasmodium genus. SBP1 proteins share a general protein structure highlighted by the absence of a signal peptide sequence and Plasmodium Export Element (PEXEL) or host targeting (HT) erythrocyte targeting motif [30, 31] , the presence of a central low complexity or repeat region (Fig 1B) , and amino acid sequence similarity confined to a region adjacent to the single transmembrane region (Fig 1C) . The central region varies in length and composition of repeat motifs. For example, in P. berghei SBP1 the central region spans roughly 500 amino acids (aa) and is composed of a tandem array of a 14 aa long repeat; whereas the P. knowlesi version lacks recognizable repeats and instead has a proline and small, polar aa rich character of approximately 100 aa length (Fig 1B) . In P. falciparum the repeat region is approximately 80 aa long and has a glycine-rich character. Similar results were obtained recently [28] .
Recombinant PkSBP1 (rPkSBP1) is exported to discrete structures in P.
knowlesi-infected monkey erythrocytes
To describe the modification of host erythrocytes by P. knowlesi we developed PkSBP1 as cellular markers by constructing plasmids expressing chimeras of sequences encoding full-length PkSBP1 fused to 2 myc epitopes at the C-terminus, to give rPkSBP1. The PkSBP1 nucleotide sequence obtained from the H-DMU line (accesion number LC155843) was different from the sequence in the database (strain H; AM910992) with one codon deletion and 18 substitutions (S1 Fig). The fragment was inserted into the transfection vector pCHD43(II) under the control of the PfCRT 5' region as a promoter (Fig 2A) . Transgenic parasites were obtained by episomal transfection to P. knowlesi (H-DMU line)-infected monkey erythrocytes. We then used imaging tools to demonstrate that chimeric protein is expressed and transported to the erythrocyte cytoplasm following infection of monkey erythrocytes. To evaluate if rPkSBP1 is expressed, asynchronous parasite cultures of parent P. knowlesi and transgenic lines were subjected to IFAT by staining with mouse anti-myc antibody. Fluorescence microscopy of the parent P. knowlesi line showed no reactivity, as was the case for uninfected erythrocytes. The rPkSBP1 was observed at all parasite stages as a punctate staining pattern in the cytoplasm of infected monkey erythrocytes (Fig 2B) . The stained puncta containing rPkSBP1 occasionally appeared to be peripheral and closely associated with the host cell membrane, especially at the trophozoite and schizont stages. The localization indicates that rPkSBP1 is expressed and exported to the infected monkey erythrocyte cytoplasm.
The primary structure of PkSBP1 protein contains a predicted transmembrane region. To evaluate whether PkSBP1 is an integral membrane protein, we performed differential extractions of infected erythrocytes and separation of the protein extracts via SDS-PAGE followed by Western immunoblotting with anti-myc antibody. A major band of approximately 50 kDa was detected in the Tx-soluble and Tx-insoluble fractions of rPkSBP1-expressing parasites, which was greater in molecular weight than the calculated full-length chimera (31.5 kDa; Fig 2C) . Also observed in the Tx fraction were an approximately 130-kDa band, a potential multimeric protein complex containing rPkSBP1; and other smaller bands at roughly 40 and 20 kDa, most likely representing processed products. PkSBP1 likely associates in membranes during blood stage infection because the majority of the rPkSBP1 was not released in the water soluble The relationship between the rPkSBP1-stained puncta and Maurer's clefts in the infected human erythrocyte was examined by co-labelling transgenic P. falciparum parasites with antiPfSBP1 and anti-myc antibodies. The antibody recognizing endogenous PfSBP1 showed complete overlap of rPkSBP1-positive puncta and PfSBP1-stained Maurer's clefts in the cytoplasm of the infected erythrocyte ( Fig 3A) . Thus, rPkSBP1 in P. falciparum is trafficked to the Maurer's clefts similarly to endogenous SBP1. Because no cellular markers have been described for P. knowlesi-infected erythrocytes, we used IFAT with anti-myc antibody and Giemsa duallabelling to examine the identity of stained structures in P. knowlesi-infected monkey erythrocytes ( Fig 3B) . The rPkSBP1-positive puncta co-localized with Giemsa-stained structures, described as 'Sinton and Mulligan' stipplings [32] , at trophozoite stage. This data suggests that the 'Sinton and Mulligan' stipplings of monkey erythrocytes infected with P. knowlesi are likely functionally analogous to Maurer's clefts.
Ultrastructural analysis of P. knowlesi-infected monkey erythrocyte
To reveal the fine structure of modifications induced by P. knowlesi infection to monkey erythrocytes, we used immunoelectron microscopy to examine the subcellular location of rPkSBP1. We observed membranous structures that were decorated with gold particles of two profiles; namely, slit-like unilamellar and oblong vesicular cleft structures (Fig 4) . We did not detect these membranous structures in uninfected erythrocytes and gold particles were not detected in the monkey erythrocytes infected with wild type P. knowlesi (S2 Fig) . This data taken together with IFAT-Giemsa dual-labelling suggests that the gold particle-positive membranous structures are identical to the 'Sinton and Mulligan' stipplings.
Full-length rPk2TM-a is expressed and exported to discrete structures in P. knowlesi-infected monkey erythrocytes
Localization of rPkSBP1 at MCs in P. falciparum prompted us to examine the location of another putative MC-resident protein, a member of the Pk2TM family, whose possible homolog in P. falciparum, Pfmc-2TM, is known to be exported to the surface of infected erythrocyte via MCs [33, 34] . To this end, we generated a transgenic P. knowlesi H-DMU line expressing recombinant Pk2TM-a (rPk2TM-a) fused to 2 myc epitopes using a plasmid constructed similarly as the one for rPkSBP1. The Pk2TM-a nucleotide sequence obtained from the H-DMU line (accession number LC155844) was different from the sequence in the database (strain H; PKNH_0623600) with 4 substitutions (S1B Fig). To confirm expression of rPk2TM-a, we performed Western immunoblotting with anti-myc antibody for parasite extracts, as described above for rPkSBP1. A single band in the Tx-insoluble fraction was detected at about 41 kDa in the rPk2TM-a-expressing parasites (Fig 5A) , suggesting that rPk2TM-a tightly associated with the membrane. IFAT images showed a punctate staining pattern in the cytoplasm of the erythrocyte infected with the Pk2TM-a-transgenic line (Fig 5B) . IEM detected rPk2TM-a on the membranous structures in the erythrocyte cytoplasm, similar to those detected for rPkSBP1 ( Fig 5C) . However, anti-myc antibody did not detect signals at the surface membrane of infected erythrocyte.
P. knowlesi induces similar modifications in monkey and human erythrocytes
To examine P. knowlesi modification of the human erythrocyte, we expressed rPkSBP1-2myc in the P. knowlesi H hu -HSPH line that was adapted to human erythrocytes. IFAT images of the transgenic parasites showed that the chimeric protein distributed as puncta in the cytoplasm of the infected human erythrocyte similar to the ones observed in the parasite-infected monkey erythrocyte (Fig 6A) . To discern the organization of the puncta and the erythrocyte membrane, rPkSBP1 and erythrocyte membrane were stained with anti-myc antibody and rat monoclonal anti-CD235a antibody, respectively; and confocal microscopy imaging was performed to obtain consecutive optical slices of the transgenic parasites expressing the rPkSBP1. 3D reconstructions of the slices (S1 Video) revealed puncta containing rPkSBP1 chimera close to the periphery of infected human erythrocytes. These structures might be tethered to the cytoskeleton as shown for P. falciparum MCs [17] . There were 'Sinton and Mulligan' stipplings in infected human erythrocytes as shown by IFAT-Giemsa dual-labelling ( Fig 6B) . We did not observe any difference in the number of 'Sinton and Mulligan' stipplings in infected human erythrocytes compared to that in infected monkey erythrocytes (S3 Fig). The subcellular location of rPkSBP1 by IEM revealed a similar staining pattern of two membrane profiles as observed in infected monkey erythrocytes (Fig 6C) . Antibody labeling was not observed in the wild type parental P. knowlesi H hu -HSPH line-infected human erythrocyte (S4 Fig) and surface structures termed caveolae in PkSBP1-transgenic P. knowlesi H hu -HSPH line (Fig 6C) . These data indicate that the morphology and number of the rPkSBP1-positive membranous structures generated in two distinguished host erythrocytes are similar and determined by the parasite, and are not influenced by possible differences in host cell factors.
Discussion
The recognition of human knowlesi malaria has allowed the opportunity to understand the mechanisms underlying the host switch from primate to human hosts [35, 36] . Successful infection and adaptation are determined by the biology of both the host and parasite. This study sought to examine how P. knowlesi modifies host erythrocytes and to determine whether adaptation to humans presented differential or new host cell modifications. Overall, we provide evidence that P. knowlesi erythrocyte modifications are determined by the parasite and not influenced by the host cell factors. In our study based on comparative bioinformatics, we have analyzed sbp1 orthologs in all Plasmodium species for which genome sequence information is available, including recently reported Plasmodium ovale and Plasmodium malariae [37] . P. knowlesi SBP1 is exported to the erythrocyte and localizes to the 'Sinton and Mulligan' stipplings of the infected erythrocyte. In P. falciparum, the mechanism of PfSBP1 transport across the parasitophorous vacuole membrane into the erythrocyte cytoplasm is via a translocon although PfSBP1 lacks a signal peptide and PEXEL/HT motif [38, 39] . Transport of PfSBP1 beyond the parasitophorous vacuole membrane to the Maurer's clefts is unclear and is possibly via vesicular trafficking or transport as a protein complex. Our findings provide evidence that PkSBP1 is exported in a similar manner to PfSBP1, and the transmembrane nature of PkSBP1 implicates rPkSBP1-positive puncta as membranous structures. The C-terminal domain of PfSBP1 is exposed to the erythrocyte cytoplasm, and it participates in protein interactions at the erythrocyte cytoskeleton [16, 17] . We did not observe any C-terminal domain homology among SBP1 orthologs, including PfSBP1 and PkSBP1; thus the functional motifs of PkSBP1 remain to be investigated. . Two myc epitopes (2myc) were fused at the C-terminus of full-length Pk2TM-a open reading frame (Pk2TM-a ORF) and expressed using the P. falciparum CRT 5' region (PfCRT 5') as a promoter. Plasmid backbone is shown in Fig 2A. (B) Western blotting of wild type parental P. knowlesi H-DMU line (WT) and Pk2TM-a-transgenic P. knowlesi H-DMU line (TG) with anti-myc antibody (α-myc). Parasite proteins were sequentially extracted by freeze-thawing (FT), followed by extraction with 1% Triton X-100 (Tx), then with 2% SDS. Parasite protein cross-reacting by an antibody against P. berghei HSP70 serves as a loading control (bottom). (C) Representative IFAT images of Pk2TM-a-transgenic P. knowlesi parasites with anti-myc antibody (α-myc, green). α-myc-stained rPk2TM-a images were merged with DAPI nucleus-staining (blue) and differential interference contrast image (merge). The top panel is a negative control. R, ring; T, trophozoite; S, schizont stages. Scale bar represents 5 μm. (D) Representative transmission electron micrographs of immunogold labeled Pk2TM. Slit-like clefts (left) and oblong vesicular clefts (right) showed gold particles in the erythrocyte cytoplasm infected with Pk2TM-a-transgenic line. c, clefts; EM, erythrocyte membrane; P, parasite. Scale bar represents 500 nm. Previous ultrastructure studies of P. knowlesi-infected monkey erythrocytes observed narrow slit-like membranous structures [13, 40] . Our analyses revealed more detail; specifically, in addition to the already described clefts, we detected oblong vesicular cleft structures in both infected monkey and human erythrocytes. We found both structures decorated with gold particle-labeled antibody, indicating that PkSBP1 and Pk2TM-a are resident on these membranes. Based on our observations, the protein composition between the slit-like and oblong vesicular membranous structures was similar, suggesting that a similar mechanism incorporates the two proteins into the structures, and/or the structures are formed by a similar process. It is formally possible that the slit-like structures and oblong vesicles observed in the P. knowlesi-infected erythrocyte correspond to the same type of structure that was just sectioned at different angles. However, oblong vesicular clefts are documented and are distinct from the slit-like membranous structures in P. falciparum-infected erythrocytes [41, 42] and oblong vesicles in P. knowlesi-infected erythrocytes appear consistently bigger than slit-like structures in majority of the ultrathin-sections collected, thus we speculate that these two types of membranous structures are distinct also for P. knowlesi. It should be noted that although the morphology is similar between these two species, to our knowledge PfSBP1 localization on the oblong vesiclar structures has not yet been reported.
Using P. falciparum as a surrogate system, successful heterologous expression and correct export of rPkSBP1 to P. falciparum MCs suggests that rPkSBP1 puncta mark structures homologous to MCs. Our data correlated the 'Sinton and Mulligan' stipplings with rPkSBP1-positive puncta when infected erythrocytes were co-labelled with Giemsa and immunofluorescent antibodies. Colocalization of the stipplings with rPkSBP1 puncta shows that the stipplings contain or are composed of proteins. Thus, we speculate the role of 'Sinton and Mulligan' stipplings to be identical to the MCs and propose to term the membranous structures positive for rPkSBP1 as Sinton and Mulligan's clefts. Taken together with findings from PfSBP1 studies, our results of rPkSBP1 and rPk2TM-a propose a model that parasiteencoded proteins are trafficked to the erythrocyte membrane via membranous structures generated by the parasite in the erythrocyte cytoplasm and this system is conserved between P. falciparum and P. knowlesi. In accordance with this, a recent report indicated that P. falciparum SBP1 was able to complement the function of its ortholog in P. berghei to modify the erythrocyte cytoadherence property [28] .
Ultrastructural analyses revealed some difference in the organization of P. knowlesi-induced membranous structures from the MCs. In P. falciparum, MCs connect to the erythrocyte membrane through tether structures [21] . Occasionally, we observed rPkSBP1-positive membranous structures beneath the infected erythrocytes membrane, but most of these structures localized distant from the infected erythrocytes surface. Accessory tether structures may then be involved in connecting the rPkSBP1-positive membranes to the erythrocyte cytoskeleton to maintain a spatial relationship enabling PkSBP1 interaction with erythrocyte cytoskeleton. This hypothesis remains to be tested in P. knowlesi.
We did not observe differences in erythrocyte modification upon P. knowlesi infection to the monkey and human erythrocytes; partly as observed by enumeration of rPkSBP1-positive puncta. Moreover, the shape, size, and distance of membranous structures from the infected erythrocytes membrane observed by TEM were comparable between infected monkey and human erythrocytes. Albeit, caution should be exercised when interpreting ultrathin sections from infected erythrocytes as they represent only two-dimensional detail from a single section. More detailed 3D analysis of the host cell modification by P. knowlesi needs to be further investigated. Nonetheless, these findings suggest that overall emerging zoonotic simian Plasmodium species are not presenting distinct protein transport pathways between natural host and human erythrocytes. While different studies have established the importance of PfSBP1 in the exposure of the virulence-related PfEMP1 on the infected erythrocytes surface and PbSBP1 in the cytoadherence activity [28] , the role of the PkSBP1 remains to be explored.
In summary, we have established markers for membranous structures in P. knowlesi by examining the localization of a newly identified SBP1 ortholog, as well as a Pk2TM protein.
We have provided evidence for the similarity of the export apparatus in terms of the existence of SBP1-positive membranous structures, with a difference in the relative location from the erythrocyte membrane between P. falciparum and P. knowlesi (as schematized in Fig 7) . Our data further strengthens the hypothesis that protein export pathways are evolutionarily conserved in the genus Plasmodium. Plasmodium protein export structures and mechanisms can be intervention targets since malaria parasites are obligate intracellular parasites that must establish new secretory pathways to transport materials across membranes and the host's cytoplasm. Intervention strategies aimed at disruption of protein export structures in the host cell augur inhibition of exposition of virulence ligands at the surface of infected erythrocytes in Plasmodium.
Materials and Methods
In silico identification of PfSBP1 orthologs and Pk2TM-a
The PfSBP1 (PF3D7_0501300) amino acid sequence without repeats was used as a query in the Basic Local Alignment Search Tool (BLAST) [43] against GenBank and PlasmoDB (http:// plasmodb.org) protein databases; hence identifying a possible ortholog in the P. knowlesi genome. Further BLASTP search using the putative PkSBP1 ortholog sequence identified putative orthologs in the P. berghei, P. vivax, P. yoelii, P. ovale and P. malariae genomes [37] . Annotation of the genes within the extended loci surrounding retrieved sbp1 genes allowed confirmation of a conserved gene synteny across Plasmodium and thereby supporting the prediction of SBP1 orthology. The protein PKNH_0623600 (former PKH_062310; termed Pk2TM-a in this study) of the 2TM family was identified from annotation of the subtelomeric regions of the P. knowlesi genome [44] . Signal peptides were identified using SignalP [45] and PkSBP1 delineates P. knowlesi host modifications. Schematic representation of host erythrocyte modifications revealed by studying the localization of SBP1 ortholog. P. knowlesi infection in both monkey and human erythrocytes induces membranous structures onto which PkSBP1 localizes. Involvement of tether structures (white bars) adjoining these membranes to the host cell cytoskeleton is possible [21] but was not investigated in this study. PfSBP1 interacts with erythrocyte membrane protein 4.1 and spectrin, as described for P. falciparum (yellow and orange shapes) [16] . PPM, parasite plasma membrane; PV, parasitophorous vacuole; PVM, parasitophorous vacuole membrane. doi:10.1371/journal.pone.0164272.g007 transmembrane regions were predicted using TMHMM 2.0 [46] . PEXEL/HT erythrocyte targeting motifs were identified by eye.
Malaria parasites
The P. knowlesi H strain was obtained from ATCC (ATCC No. 30158) and maintained in Japanese macaques (Macaca fuscata) in Dokkyo Medical University, Japan, herein termed the "H-DMU" line, and was adapted to propagate in vitro. These monkeys were second-generation offspring bred in captivity. All monkeys were bred and grown at animal facilities in a malariafree environment in Japan, housed in individual cages (cage size: 650[W] x 750[D] x 820[H] mm) in a controlled environment (22-25°C and 30-60% humidity and 12-hour light/dark cycle). They were fed a standard diet for the old world monkey supplemented with fresh fruits and given water ad libitum. The investigators adhered to the Guidelines for the Use of Experimental Animals authorized by the Japanese Association for Laboratory Animal Science. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Dokkyo Medical University (Permit Number: 0656). The monkeys were intravenously inoculated with frozen stock of P. knowlesi-infected erythrocytes. For hematological examination, venous blood samples were obtained every 3 or 4 days after inoculation. These procedures were performed under anesthesia with a combination of ketamine hydrochloride (10 mg/kg, i.m.) and xylaxine (0.5 mg/kg, i.m.), and all efforts were made to minimize suffering. From day 1 after inoculation, Giemsa-stained thin blood films were prepared daily from peripheral blood obtained by earprick, and development of parasites in the infected monkeys was monitored by microscopic observation. After parasite inoculation, monkeys were monitored daily by a veterinarian during the experiment for clinical signs (e.g., changes in respiration and appetite), body condition (visual inspection of the obesity and leanness), and well-being (e.g., changes of fur and a lack of atypical behavior). The humane endpoint for the infectious experiment was determined when parasitemia in the peripheral blood reached to 5%, and all animals were exsanguinated under deep anesthesia by the combination of ketamine hydrochloride/xylaxine/ pentobarbitone (30 mg/kg, i.v.). The details of animal welfare/care and steps taken to ameliorate suffering were in accordance with the recommendations of the Weatherall report "The use of non-human primates in research". Human erythrocyte-adapted P. knowlesi H strain, herein termed the "H hu -HSPH" line, was provided by M. Duraisingh (Harvard T. H. Chan School of Public Health, MA, USA) [11] . The P. falciparum MS822 field isolate from Mae Sot, Thailand was described before [47] .
Culture conditions for malaria parasites P. knowlesi H-DMU line parasites were cultivated in RPMI-1640 medium supplemented with 0.5% AlbuMAX lI (Invitrogen, Carlsbad, CA), 200 mM hypoxanthine (Sigma, St. Louis, MO), 20 μg/ml gentamicin (Invitrogen) and rhesus macaque erythrocytes at 2% hematocrit. Usage of rhesus monkey blood was approved by the Animal Care and Use Committee, the Corporation for Production and Research of Laboratory Primates, Japan, and the monkey blood were provided from Non-human Primate Reagent and Resource Program in Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Japan. P. knowlesi H hu -HSPH line parasites were cultivated under similar conditions as above except using O + human erythrocytes. P.
falciparum was maintained in RPMI-1640 medium containing 5% heat-inactivated pooled type AB + human serum, 0.25% AlbuMAX I (Invitrogen), 200 mM hypoxanthine, 20 μg/ml gentamicin and O + human erythrocytes at 2% hematocrit.
Plasmid construction
The PKNH_1032400 gene (former ID PKH_103200) was identified as encoding PkSBP1 as above and was amplified from P. knowlesi H-DMU line genomic DNA using KOD -Plus-DNA polymerase (Toyobo, Japan) with primers PKH_103200_s (GGGCTAGCTAAAAAATG TGTCAAGCATTTGCAAGT) and PKH_103200_as (GTGGTACCAATGGCATCTCCATCGAGTT). The PKNH_0623600 (Pk2TM-a) gene was amplified with PKH_062310_s (GGGCTAGCTAA AAAATGAAAGAAATATTTCTGTTC) and PKH_062310_as (GTGGTACCTTCTTTAATTTTAA CACCGT). The primer pairs for each gene contained Nhel and KpnI sites (shown in bold). The purified PCR products were ligated into the Nhel and KpnI sites in pB1/3_2myc vector using T4 DNA ligase (Promega, Madison, WI). pB1/3_2myc is a pUC19-based plasmid containing attB1 and attB3. Using the Multisite Gateway system (Invitrogen) to prepare plasmids, BP recombination reactions of pDONR™P1-P3 (Invitrogen), which was generated from pDONR™221 (Invitrogen) by replacing attP2 motif to attP3 motif, with pB1/3_PkSBP1-2myc and pB1/3_Pk2TM-a-2myc were performed to obtain the entry clones pENTR1/3_PkSBP1-2myc and pENTR1/3_Pk2TM-a-2myc, respectively. The pENTR1/3-based plasmids were subjected to a Gateway Multisite LR recombination reaction with pENTR4/1_PfCRT5' and pCHD43(II) [48, 49] . The plasmids pENTR4/1_PfCRT5' and pCHDR-3/4 (origin of pCHD43 (II)) are gifts from G. McFadden (University of Melbourne, Australia). The plasmids obtained were verified by analyzing the restriction enzyme digestion pattern and nucleotide sequencing.
Generation of transgenic parasites
Mixed asexual stages of P. knowlesi parasites were transfected using Amaxa Nucleofector 2b (Lonza, Switzerland) and Amaxa Human T cell kit (Lonza). Approximately 50 μg of plasmid DNA in incomplete cytomix (120 mM KCl, 0.15 mM CaCl 2 , 2 mM EGTA, 5 mM MgCl 2 , 10 mM K 2 HPO 4 , and 25 mM HEPES) was added to 100 μl of human T cell nucleofector solution. 1x10 7 -10 8 parasites were resuspended in the DNA-human T cell nucleofector solution mixture in Nucleofector kit cuvettes (Lonza) and electroporated using the U-33 program. The cuvettes were immediately put on ice and then the electroporated cells were transferred to a tissue culture flask containing 10 ml of 37°C-prewarmed complete medium and rhesus monkey or human erythrocytes to a final hematocrit of 2%. Three nanomolar of antifolate drug WR99210 (a gift from D. Jacobus, Jacobus Pharmaceutical Co. Inc., USA) was supplied in culture medium starting 24 hours post transfection. The drug pressure was maintained continuously. P. falciparum MS822 parasites were transfected using the erythrocyte loading method as described [50] . Briefly, human erythrocytes were suspended in 400 μl of incomplete cytomix containing 50 μg of plasmid DNA. Electroporation was performed in 2 mm cuvettes using the Gene Pulser Xcell Electroporation system (Bio-Rad, Hercules, CA) with a set program of 0.32 kV and 950 μF. Mixed stage parasite culture was resuspended with plasmid-preloaded erythrocytes (final parasitemia 0.1%). Five nanomolar WR99210 was supplied in culture medium starting on day 4 post transfection until drug-resistant parasites appeared, then parasites were maintained with 10 nM WR99210 henceforth.
Immunofluorescence microscopy
For indirect immunofluorescence antibody test (IFAT) thin blood films on glass slides were prepared from mixed stage cultures with 3-10% parasitemia, air-dried at room temperature (RT), and kept at −80°C till further use. Retrieved blood films were thawed at RT in a silica gel desiccator and were fixed at RT for 15 min using 4% paraformaldehyde (Nacalai Tesque, Japan) and 0.075% glutaldehyde (Nacalai Tesque, Japan) in phosphate-buffered saline (PBS used as a mounting solution. Alternatively, instead of thin blood films, cells fixed within a tube were permeabilized with 0.1% Triton X 100 in PBS and reacted with antibodies. Cells were let to settle on glass slides and gently covered with a mounting solution and coverslip. Visualization of images was performed using either a fluorescent microscope (Axio Imager Z2; Carl Zeiss, Germany) equipped with a 100x/1.4 oil immersion lens and a CCD camera (AxioCam MRm; Carl Zeiss), or a laser scanning confocal microscope system (LSM 780 ELYRA system, Carl Zeiss). Some acquired images were processed and analyzed using Adobe Photoshop CS (Adobe Systems Inc. San José, CA) or IMARIS processing software (Version 7.2 Bitplane Inc, Switzerland) for 3D reconstruction. To enumerate the number of anti-myc antibody-positive dots, IFAT images were counted for 30 randomly selected transgenic parasites expressing recombinant PkSBP1-2myc (rPkSBP1) in the monkey or human erythrocytes. The median value for each parasite was determined, and statistical differences were evaluated by Mann-Whitney U test implemented in GraphPad PRISM™ 6 (GraphPad Software, Inc., San Diego, CA).
For IFAT-Giemsa co-staining, monolayer blood films were prepared for IFAT and images were acquired as in the IFAT section above. During image acquisition, the mechanical stage was used to record vernier coordinates (precision ± 0.1 mm) of parasites whose fluorescent images had been acquired. Coverslips were removed from the glass slides, the mounting solution was removed by washing the slides with methanol for 30 seconds followed by 2 min wash with PBS. The slides were then stained with 10% Giemsa azur eosin methylene blue solution (Merck Millipore) in phosphate buffer (pH 6.8) for 90 min. The slides were washed with water for 1 min and parasites at the same vernier coordinates were tracked and imaged using a light microscope (Eclipse 80i; Nikon, Japan; 100x/1.3 oil immersion lens) fitted with a CCD camera (VB-7010; Keyence, Japan).
Immunoelectron microscopy (IEM)
Parasite pellets were fixed by incubating in 0.1 M phosphate buffer (pH7.4) containing 4% paraformaldehyde and 0.1% glutaraldehyde on ice for 15 min. The pellets were rinsed thrice with 0.1 M phosphate buffer, dehydrated with ethanol series (30%, 50%, 70%, then 95%), each time at 4°C for 5 min, and embedded in LR White resin (London Resin Company, UK) as described [51] . Thin sections were obtained using an ultramicrotome (Reichert-Jung, Austria) and blocked at 37°C for 30 min with 5% non-fat milk (Becton, Dickinson, and Company, NJ) and 0.0001% Tween 20 (Wako) in PBS (PBS-MT). Sections on the grid were then incubated at 4°C overnight with mouse anti-myc antibody (1:100; 9B11) or control normal mouse IgG in PBS-MT. After washing with PBS containing 5% Blocking One buffer (Nacalai Tesque) and 0.0001% Tween 20 (PBS-BT), the sections were incubated at 37°C for 1 h with goat anti-mouse IgG conjugated to 15 nm gold particles (EY Laboratories, CA) diluted 1:20 in PBS-MT, rinsed with PBS-BT, and fixed with 0.5% OsO 4 (Nacalai Tesque) at RT for 5 min to stabilize the gold. Finally, the sections were rinsed with distilled water, dried, and stained with uranyl acetate and lead citrate. Samples were examined at 80 kV under a transmission electron microscope (JEM-1230; JEOL Ltd., Japan). The images were processed using Adobe Photoshop CS.
SDS-PAGE and immunoblotting
Protein fractions were prepared from erythrocytes infected with asynchronous parasites expressing either rPkSBP1 or rPk2TM-a after 0.15% saponin permeabilization in PBS containing a protease inhibitor (PI) cocktail tablet (cOmplete, EDTA-free; Roche Basel, Switzerland) and 1 mM EDTA (PBS-PI). The parasites were pelleted, washed with PBS-PI, and frozen at −80°C until further use. The water soluble fraction (FT) was obtained by freeze-thawing the pellet thrice at −80°C. The parasites were washed thrice with PBS-PI. A 1% solution of Triton X-100 (Tx; Calbiochem, San Diego, CA) detergent was used to resuspend the parasite pellets and the water insoluble fraction was collected after incubation on ice for 30 min. Tx-insoluble pellets were washed thrice with PBS-PI containing Tx. The Tx-insoluble fraction was extracted with 2% sodium dodecyl sulfate (SDS; Nacalai Tesque) in PBS-PI at RT for 30 min. Parasite extracts were adjusted for equal loading (~10 7 /lane) and were subjected to electrophoresis on 5-20% SDS-polyacrylamide gradient mini gels (ATTO, Japan) in a reducing condition. The proteins were transferred onto polyvinylidene fluoride (PVDF) membranes (Merck Millipore) and probed with mouse anti-myc monoclonal antibody (final 1:1000) at RT for 1 h. The blotted membrane was incubated with a solution containing horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG secondary antibody (final 1:25,000, Promega) at RT for 30 min. Mouse monoclonal antibody against Plasmodium berghei heat-shock protein 70 (HSP70) that cross-reacts with the orthologs of other Plasmodium spp. was obtained from J. Sattabongkot (Mahidol University, Thailand) [52] . Reactivity was visualized with Immobilon™ Western Chemiluminescent HRP substrate (Merck Millipore) and detected using a chemiluminescence detection system (LAS-4000EPUVmini; Fujifilm, Japan). The relative molecular sizes of the protein bands were calculated based on reference to the molecular size standards (Precision Plus Protein™ Dual Color Standards; Bio-Rad).
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